What is BioDRestore?
BioDRestore is a novel placental tissue allograft. Placental tissues have been shown clinically and scientifically to support soft tissue repair, reduce inflammation and minimize scar tissue formation.
BioDRestore is derived from tissues acquired from living, healthy donors after full term pregnancy and a scheduled Caesarean section. These tissues have been minimally processed and preserved to maintain the natural properties of the placental tissues.
The product is only available through a physician or licensed healthcare provider.
What is an Allograft?
An allograft is tissue from a human donor that is transplanted from one body to another.
Why the Placental Tissues?
Clinicians have used the placental tissues for over a century as a biologic dressing in a broad range of therapeutic applications. It has been generally recognized as a versatile wound covering with published clinical results cited extensively in the literature. The placental tissues are an abundant source of collagen, as well as the other proteins, growth factors and cells that are essential to support the body’s natural regenerative healing process.
Studies have described the placental tissues as “immuneprivileged” because they rarely evoke an immune response in the human body. In addition, studies have shown that the placental tissues may be helpful in treating soft tissue injuries or localized areas of inflammation such as tendinitis.
Safety & Quality Are Our Highest Priorities.
BioD products are processed in accordance with the standards and regulations set forth by the Food and Drug Administration (FDA) and American Association of Tissue Banks (AATB) for allograft tissue products. Our processes have been developed to preserve the placental tissues’ natural characteristics, including the extracellular matrix, growth factors and inherent cells, and to provide clinically efficacious products.
BioDRestore is derived from living, healthy donors that are prescreened during pregnancy and selected based on our stringent donor suitability criteria. In addition to reviewing pre-natal test results, BioD obtains a comprehensive medical history and behavioral risk assessment from each consenting donor prior to recovery. From aseptic processing to lot release testing of all of our tissues, we are committed to the safety and quality of our products.
Are There Risks Associated With the Use of BioDRestore?
BioDRestore is an allograft that contains tissues from a living, healthy donor. As with the implantation of any human tissue, there is always the possibility of an adverse allergic reaction or transmission of a communicable disease in connection with the use of this product. Over 15,000 allografts distributed by BioD have been used in dental, ocular, orthopedic and wound care applications.
BioDRestore is a flowable tissue product that will allow your doctor to apply the product right at the source of injury. Your physician can determine if your medical condition is appropriate for treatment with BioDRestore and, if so, will advise you as to the number and frequency of recommended treatments based on his or her professional assessment of your condition.
Common injuries treated with Placental Tissues:
- Repetitive Motion Injuries
- Plantar Fasciitis
- Soft Tissue Injuries
- Muscle Tears
- Inflamed Nerves
BioD’s Commitment to Regenerative Science
BioDRestore is processed and distributed by BioD, LLC, a regenerative medicine company engaged in the development of advanced biologic products derived from placental tissues. Our research and development efforts are focused on the regenerative potential of birth tissues* given their unique biologic structure and the immune privilege that characterizes their function in the body.
Quite simply, we believe the use of live healthy donors is a better approach to regenerative medicine.
*BioD does not use fetal demise tissue or cloned cells in its products.